Ondine Biomedical Inc.
OBIMF
$0.14
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.73% | -8.06% | 2.57% | -46.52% | 1.47% |
| Total Depreciation and Amortization | 3.70% | 7.57% | -2.52% | -0.77% | -1.42% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.72% | -47.16% | -2.57% | 102.04% | -1.51% |
| Change in Net Operating Assets | 3.72% | -14.25% | -2.56% | 9,962.32% | -1.43% |
| Cash from Operations | -3.73% | -18.06% | 2.57% | -19.05% | 1.47% |
| Capital Expenditure | -3.57% | -- | -- | 100.00% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.57% | -- | -- | 100.00% | 0.00% |
| Total Debt Issued | -- | -- | 0.00% | -- | -- |
| Total Debt Repaid | 0.00% | 70.54% | 0.00% | -230.36% | 0.00% |
| Issuance of Common Stock | 0.00% | -65.89% | 0.00% | 179.27% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 98.41% | 0.00% | -151.09% | 0.00% |
| Cash from Financing | 3.73% | -67.21% | -2.57% | 212.32% | -1.47% |
| Foreign Exchange rate Adjustments | 3.70% | -40.72% | -2.57% | 1,146.67% | -1.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.73% | -149.68% | -2.57% | 585.54% | 1.48% |